Clinical trial

Potential Therapeutic Implications of Acutaping on Nausea and Vomiting During Pregnancy

Name

Acutaping for NVP

Description

This study will answer the following research question: Is acutaping has therapeutic implications on symptoms of nausea and vomiting during pregnancy?

Trial arms

Trial start

2023-02-03

Estimated PCD

2023-12-15

Trial end

2023-12-15

Status

Completed

Treatment

Acutaping

Application of the kinesio tape on finger and forearm flexor tape after localization of the acupoints of application

Arms:

acutaping and traditional medical treatment

Doxylamine and Pyridoxine

traditional medical treatment for nausea and vomiting during pregnancy

Arms:

acutaping and traditional medical treatment, traditional medical treatment only

Size

Primary endpoint

pregnancy unique quantification of emesis and nausea questionnaire

Measured before treatment , after first treatment (at 4th day) and after second treatment (at 8th day )

pregnancy unique quantification of emesis and nausea questionnaire

Measured before treatment , after first treatment (at 4th day) and after second treatment (at 8th day )

Eligibility criteria

Inclusion Criteria: * Woman with nausea and vomiting during pregnancy Primigravida With age ranges from 20-35years Gestational age 7-16 weeks Body mass index (BMI) less than 30 kg/m2 Not hospitalized due to hyperemesis gravidarum Exclusion Criteria: * Gastrointestinal disorder Diabetes Dehydration

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Participants will be randomly allocated into two groups; group (A) will receive acutaping in addition to traditional medical treatment (Doxylamine and Pyridoxine) while group (B) will receive traditional medical treatment(Doxylamine and Pyridoxine) only.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 27, 'type': 'ACTUAL'}}

Updated at

2024-02-16

1 organization

1 product

2 indications

Organization

Kafrelsheikh University

Product

Doxylamine + Pyridoxine

Indication

Nausea

Indication

Nausea and Vomiting of Pregnancy